Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Expands By 585.7%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 14,400 shares, a growth of 585.7% from the October 31st total of 2,100 shares. Based on an average daily trading volume, of 14,300 shares, the short-interest ratio is presently 1.0 days.

Reviva Pharmaceuticals Stock Up 22.9 %

Reviva Pharmaceuticals stock traded up $0.04 during trading hours on Wednesday, hitting $0.23. 100 shares of the stock traded hands, compared to its average volume of 16,188. Reviva Pharmaceuticals has a 1 year low of $0.07 and a 1 year high of $1.62. The firm’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.18.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.